.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Business PracticeSee All >

Business
Development
Legal
Policy
Practice
Regulatory

About
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

Clinician and Managed Care Insights on Biosimilars for Inflammatory Diseases

EP. 1: Knowledge Gaps With Biosimilars

June 17th 2017

EP. 2: Differences Between Biosimilars and Generic Drugs

June 17th 2017

EP. 3: Approval Process for Biosimilars

June 17th 2017

EP. 4: Naming of Biosimilars

June 17th 2017

EP. 5: Clinical Experience With Biosimilars

June 17th 2017

EP. 6: Use of Biosimilars in Inflammatory Diseases

June 17th 2017

EP. 7: Cost and Prescribing Considerations for Biosimilars

June 17th 2017

EP. 8: Variables Affecting Cost for Biosimilars

June 17th 2017

EP. 9: Formulary Considerations for Biosimilars

June 17th 2017

EP. 10: Challenges in Discussing Biosimilars With Patients

June 17th 2017